Imexpharm Corporation

IMP

VN000000IMP0

Pharmaceuticals

End-of-day quote Ho Chi Minh S.E. Other stock markets 03:30:00 31/05/2024 am IST			5-day change	1st Jan Change
68,100 ^VND	+0.15%		+0.89%	+20.32%

27/05	Imexpharm Corporation Appoints Tnrong Minh Hung, A Non-Executive Member of the Board of Directors, as A Member of the Audit Committee Under the Board of Directors	CI
19/04	Imexpharm Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Imexpharm Corporation Announces Executive Appointments

June 27, 2018 at 02:39 pm IST

The board of Imexpharm Corporation approved the appointment of Mr. Nguyen Quoc Dinh as the Chairman of BOD and Ms. Tran Thi Dao as Vice Chairman of BOD cum CEO.

Latest news about Imexpharm Corporation

Imexpharm Corporation Appoints Tnrong Minh Hung, A Non-Executive Member of the Board of Directors, as A Member of the Audit Committee Under the Board of Directors	27/05	CI
Imexpharm Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	19/04	CI
Imexpharm Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	20/01	CI
Imexpharm Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	20/01	CI
Imexpharm Corporation Approves Election of Hoang Duc Hung as an Independent Member of the Board of Directors	20/12	CI
Imexpharm Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	19/23/19	CI
Imexpharm Corporation Announces Dividend, Payable on October 20, 2023	18/23/18	CI
Imexpharm Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	19/23/19	CI
Imexpharm Corporation Appoints Chun Chaerhan as Chairperson of the Board of Directors	05/23/05	CI
Imexpharm Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	18/23/18	CI
Imexpharm Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	17/23/17	CI
Imexpharm Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	17/23/17	CI
Imexpharm Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	18/22/18	CI
Imexpharm Corporation announced that it has received funding from SK Group Ltd.	25/22/25	CI
Imexpharm Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	18/22/18	CI
Imexpharm Corporation Announces Personnel Change	31/22/31	CI
Imexpharm Corporation Announces Cash Dividend for 2021, Payable on June 24, 2022	13/22/13	CI
Imexpharm Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	18/22/18	CI
Imexpharm Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	20/22/20	CI
Imexpharm Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	18/21/18	CI
Imexpharm Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2021	20/21/20	CI
Imexpharm Corporation Reports Earnings Results for the First Quarter Ended March 31, 2021	19/21/19	CI
Imexpharm Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2020	19/21/19	CI
Imexpharm Corporation Reports Earnings Results for the Nine Months of 2020	29/20/29	CI
Imexpharm Corporation Provides Earnings Guidance for the Fourth Quarter and Full Year of 2020	29/20/29	CI

Imexpharm Corporation is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures, imports, exports and trades pharmaceutical products, antiseptics, traditional medicine, medical equipment and supplies, cosmetics, supplemental food and drinks. It is also involved in the provision of packaging services and warehousing services for pharmaceutical storage purposes. In addition, the Company is involved in medicinal herb cultivation.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

68,100 VND

Average target price

77,033 VND

Spread / Average Target

+13.12%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
IMEXPHARM CORPORATION	+20.32%	187M
ELI LILLY AND COMPANY	+40.73%	739B
NOVO NORDISK A/S	+32.83%	598B
JOHNSON & JOHNSON	-6.30%	353B
MERCK & CO., INC.	+15.15%	318B
ABBVIE INC.	+4.05%	285B
ASTRAZENECA PLC	+15.00%	240B
NOVARTIS AG	+9.78%	210B
ROCHE HOLDING AG	-5.52%	206B
AMGEN INC.	+6.17%	164B

Other Pharmaceuticals